pharmacopeia

Mechanism of action

Sourced from openFDA

Mechanism-of-action class: Adrenergic alpha-Agonists.

Indications

Sourced from openFDA
  • Use relieves redness of the eye due to minor eye irritations

Dosage & administration

Sourced from openFDA

Directions instill 1 to 2 drops in the affected eye(s) up to 4 times daily

Warnings & precautions

Sourced from openFDA

For external use only Ask a doctor before use if you have narrow angle glaucoma When using this product pupils may become enlarged temporarily to avoid contamination, do not touch tip of container to any surface. Replace cap after using. if solution changes color or becomes cloudy, do not use overuse may produce increased redness of the eye remove contact lenses before using Stop use and ask a doctor if you experience eye pain changes in vision continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

FAERS reports

View JSON
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
326 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
  1. 1Fatigue10532%
  2. 2Headache9730%
  3. 3Off Label Use9629%
  4. 4Drug Ineffective9529%
  5. 5Pain9228%
  6. 6Rash9128%
  7. 7Abdominal Discomfort8827%
  8. 8Weight Decreased8827%
  9. 9Inappropriate Schedule Of Product Administration8727%
  10. 10Pyrexia8727%
  11. 11Condition Aggravated8526%
  12. 12Pain In Extremity8526%
  13. 13Tinnitus8526%
  14. 14Confusional State8426%
  15. 15Dysgeusia8426%

Clinical trials

View JSON

The 10 most recently updated of 26 ClinicalTrials.gov registrations naming Tetrahydrozoline as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

Frequently asked questions

How does Tetrahydrozoline work?
Mechanism-of-action class: Adrenergic alpha-Agonists.
What is Tetrahydrozoline used for?
According to FDA labeling, Tetrahydrozoline carries indications including: Use relieves redness of the eye due to minor eye irritations. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
What class of drug is Tetrahydrozoline?
Tetrahydrozoline is classified as Sympathomimetics, combinations excl. corticosteroids, Sympathomimetics, plain, Sympathomimetics used as decongestants, Adrenergic alpha-Agonists, Conjunctival Arterial Vasoconstriction, Decreased Nasal and Sinus Secretions.
What are the brand names for Tetrahydrozoline?
Tetrahydrozoline is marketed under brand names including Altazine, Optigene, Visine.
Note. Data for tetrahydrozoline is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.

Search pharmacopeia

Search drugs, classes, and ingredients